Showing results (81-90 of 182) with videos related to
Sort By:
Pageof 19
Molecular Pharmacology|December 1, 1986
High yield photoaffinity labeling of angiotensin II receptorsG Guillemette, G Guillon, J Marie, et al.The Journal of Biological Chemistry|August 5, 1985
Anti-substance P anti-idiotypic antibodies. Characterization and biological activitiesJ Y Couraud, E Escher, D Regoli, et al.The Journal of Biological Chemistry|September 20, 1996
Identification of transmembrane domain residues determinant in the structure-function relationship of the human platelet-activating factor receptor by site-directed mutagenesisJ L Parent, C L Gouill, E Escher, et al.Drug Testing and Analysis|March 13, 2025
Quantitative Investigation of Nitrosamine Drug Substance-Related Impurities (NDSRIs) Under Artificial Gastric Conditions by Liquid Chromatography-Tandem Mass Spectrometry and Structure-Activity Relationship AnalysisMatthias Vogel, Sylvia E Escher, Emanuel Weiler, et al.Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2014
Structural features of endocrine active chemicals--A comparison of in vivo and in vitro dataGeertje Lewin, Sylvia E Escher, Bart van der Burg, et al.Receptors & Channels|May 9, 2000
Different populations of inositol 1,4,5-trisphosphate receptors expressed in the bovine adrenal cortexM Poitras, S N Poirier, K Laflamme, et al.Journal of Leukocyte Biology|August 31, 2001
Hemofiltrate CC chemokines with unique biochemical properties: HCC-1/CCL14a and HCC-2/CCL15U Forssmann, H J Mägert, K Adermann, et al.European Journal of Pharmacology|February 12, 1985
Substance P antagonists showing some selectivity for different receptor typesD Regoli, J Mizrahi, P D'Orléans-Juste, et al.European Journal of Pharmacology|November 26, 1985
Tachykinin receptors in smooth muscles: a study with agonists (substance P, neurokinin A) and antagonistsJ Mizrahi, S Dion, P D'Orléans-Juste, et al.Regulatory Toxicology and Pharmacology : RTP|October 11, 2011
Improvement of the Cramer classification for oral exposure using the database TTC RepDose--a strategy descriptionI Tluczkiewicz, H E Buist, M T Martin, et al.Pageof 19